Lipum is a biopharmaceutical company specialized on a novel way to treat chronic inflammatory diseases. For more information, see www.lipum.se.
Lipum AB was listed on Nasdaq First North Growth Market on 22 April 2021.
HWF Advokater advised Lipum in connection with the listing.
